Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation

被引:73
|
作者
Aversa, A. [1 ]
Pili, M.
Francomano, D.
Bruzziches, R.
Spera, E. [2 ]
La Pera, G. [3 ]
Spera, G.
机构
[1] Univ Roma La Sapienza, Dept Med Pathophysiol, Chair Internal Med, DFM, I-00161 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Urol, Rome, Italy
[3] Azienda Osped San Camillo, Rome, Italy
关键词
phosphodiesterase type-5 inhibitor; IELT; PERT; ejaculatory control; treatment; PHOSPHODIESTERASE TYPE-5 INHIBITORS; SEMINAL-VESICLE TISSUE; REFRACTORY TIME; DRUG-TREATMENT; SILDENAFIL; EFFICACY; DEFINITION; VALIDATION; TADALAFIL; RESPONSES;
D O I
10.1038/ijir.2009.21
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Premature ejaculation (PE) is thought to be the most common male sexual dysfunction; however, the prevalence of lifelong (LL)-PE is relatively low. The aim of this study was to investigate the effects of on-demand vardenafil (10 mg) to modify the intravaginal ejaculatory latency time (IELT) in men with LL-PE without erectile dysfunction. Forty-two men (18-35 years) were enrolled in a 16-week, double-blind, placebo-controlled, cross-over study. Primary end point was the modification from baseline of IELT assessed by stopwatch technique; secondary end points were post-ejaculatory refractory time (PERT) and variations of scores at the Index of Premature Ejaculation questionnaire. The changes in geometric mean IELT were superior after taking vardenafil (0.6 +/- 0.3 vs 4.5 +/- 1.1 min, P < 0.01), compared with placebo (0.7 +/- 0.3 vs 0.9 +/- 1.0 min, ns). PERT dropped significantly after vardenafil (16.7 +/- 2.0 vs 4.3 +/- 0.9 min, P < 0.001), compared with placebo (15.3 +/- 2.2 vs 15.8 +/- 2.3 min). Patients who took vardenafil (vs placebo) reported significantly (P < 0.01) increased ejaculatory control (6 +/- 2 vs 16 +/- 2), improved overall sexual satisfaction (7 +/- 2 vs 15 +/- 1) and distress (4 +/- 1 vs 8 +/- 1) scores, respectively. Multiple regression analysis (r(2) = 0.86) for IELT by the number of attempts at sexual intercourse showed significant differences between the slopes of lines for placebo and vardenafil (P < 0.0001). The most common adverse events for vardenafil (vs placebo) were headache (10 vs 3%), flushing (12 vs 0%) and dyspepsia (10 vs 0%), which tended to disappear over the time. In conclusion, in our study, vardenafil increased IELT and reduced PERT in men with LL-PE. Besides, improvements in confidence, perception of ejaculatory control and overall sexual satisfaction were reported. International Journal of Impotence Research (2009) 21, 221-227; doi: 10.1038/ijir.2009.21; published online 28 May 2009
引用
收藏
页码:221 / 227
页数:7
相关论文
共 50 条
  • [1] Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation
    A Aversa
    M Pili
    D Francomano
    R Bruzziches
    E Spera
    G La Pera
    G Spera
    [J]. International Journal of Impotence Research, 2009, 21 : 221 - 227
  • [2] Effects of Vardenafil Administration on Intravaginal Ejaculatory Latency Time in Men With Lifelong Premature Ejaculation Editorial Comment
    Aversa, A.
    Pili, M.
    Francomano, D.
    Bruzziches, R.
    Spera, E.
    La Pera, G.
    Spera, G.
    [J]. JOURNAL OF UROLOGY, 2009, 182 (06): : 2859 - 2859
  • [3] VARDENAFIL AMELIORATES INTRAVAGINAL EJACULATORY LATENCY TIME BY MODULATING SYMPATHETIC TONE IN MEN WITH LIFELONG PREMATURE EJACULATION: A PILOT STUDY
    Aversa, A.
    Francomano, D.
    Bruzziches, R.
    Lenzi, A.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 330 - 331
  • [4] Can Estimated Intravaginal Ejaculatory Latency Time Be Used Interchangeably With Stopwatch-measured Intravaginal Ejaculatory Latency Time for the Diagnosis of Lifelong Premature Ejaculation?
    Lee, Won Ki
    Cho, Sung Tae
    Lee, Yong Seong
    Lee, Young Goo
    Oh, Cheol Young
    Yoo, Changhee
    Cho, Jin Seon
    Shin, Tae Young
    Lee, Sang Kon
    Lee, Seong Ho
    Ko, Kyungtae
    Yang, Dae Yul
    [J]. UROLOGY, 2015, 85 (02) : 375 - 380
  • [5] Premature Ejaculation: Bother and Intravaginal Ejaculatory Latency Time in Iran
    Zargooshi, Javaad
    [J]. JOURNAL OF SEXUAL MEDICINE, 2009, 6 (12): : 3478 - 3489
  • [6] Effects of paroxetine on intravaginal ejaculatory latency time in Egyptian patients with lifelong premature ejaculation as a function of serotonin transporter polymorphism
    A M Salem
    I I Kamel
    L A Rashed
    S F GamalEl Din
    [J]. International Journal of Impotence Research, 2017, 29 : 7 - 11
  • [7] Effects of paroxetine on intravaginal ejaculatory latency time in Egyptian patients with lifelong premature ejaculation as a function of serotonin transporter polymorphism
    Salem, A. M.
    Kamell, I. I.
    Rashed, L. A.
    Din, S. F. GamalEl
    [J]. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2017, 29 (01) : 7 - 11
  • [8] TREATMENT OUTCOMES IN MEN WITH PREMATURE EJACULATION TREATED WITH DAPOXETINE BY THEIR BASELINE INTRAVAGINAL EJACULATORY LATENCY TIME
    Brock, Gerald B.
    Althof, Stanley E.
    Rosen, Raymond C.
    Bull, Scott
    Tesfaye, Fisseha
    Rothman, Margaret
    Aquilina, Joseph W.
    [J]. JOURNAL OF UROLOGY, 2009, 181 (04): : 529 - 529
  • [9] ASSESSMENT OF INTRAVAGINAL EJACULATORY TIME IN LIFELONG PREMATURE EJACULATION PATIENTS WITH AND WITHOUT MONOSYMPTOMATIC ENURESIS
    Koyuncu, Hakan
    Serefoglu, Ege Can
    Karacay, Safak
    Ozdemir, Ahmet Tunc
    Yencilek, Faruk
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E462 - E462
  • [10] ASSESSMENT OF INTRAVAGINAL EJACULATORY TIME IN LIFELONG PREMATURE EJACULATION PATIENTS WITH AND WITHOUT MONOSYMPTOMATIC ENURESIS
    Koyuncu, Hakan
    Serefoglu, E.
    Karacay, Safak
    Ozdemir, Ahmet Tunc
    Yencilek, Faruk
    [J]. JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 14 - 14